NICE

Bristol-Myers' Opdivo racks up latest NICE rejection, this time in head and neck cancer
Fierce Pharma
Wed, 04/12/17 - 06:07 pm
Bristol-Myers Squibb
Opdivo
NICE
head and neck cancer
UK cost agency rejects Bristol's Opdivo for kidney cancer
Yahoo/Reuters
Tue, 07/5/16 - 10:23 am
UK
Bristol-Myers Squibb
Opdivo
kidney cancer
NICE
GSK's lupus drug finally wins NICE backing, but only after discounts
BioPharma Dive
Thu, 05/12/16 - 09:40 am
GSK
lupus
NICE
UK
Benlysta
Bristol-Myers' Opdivo Gets Nod for Melanoma From U.K. Regulator
Bloomberg
Thu, 01/21/16 - 07:52 pm
Bristol-Myers Squibb
Opdivo
melanoma
UK
NICE
Bristol's drug pricing under fire as UK agency rejects Opdivo
Yahoo/Reuters
Wed, 12/16/15 - 10:07 am
Bristol-Myers Squibb
UK
Opdivo
NICE
Amgen's Repatha gets a thumbs-down from U.K. cost-effectiveness watchdogs
Fierce Pharma
Wed, 11/18/15 - 10:15 pm
Amgen
Repatha
NICE
UK
PCSK9 inhibitors
U.K. cost gatekeeper says 'OK' to Merck's Keytruda for advanced skin cancer
Fierce Pharma
Wed, 10/7/15 - 03:15 pm
UK
Merck
Keytruda
skin cancer
NICE
Daiichi clot-buster wins a NICE green light, but still faces an uphill track
Fierce Biotech
Wed, 08/12/15 - 12:41 pm
Daiichi Sankyo
bloodthinners
Lixiana
edoxaban
NICE
NICE sings a different tune for Bayer's prostate cancer drug Xofigo
Fierce Pharma
Fri, 06/5/15 - 11:03 am
NICE
Bayer
prostate cancer
Xofigo
Roche, Novartis and Bayer snag NICE OKs
Fierce Pharma
Tue, 06/2/15 - 04:50 pm
NICE
Roche
Novartis
Bayer
Gazyvaro
Cosentyx
Eylea
Cost watchdogs back Novartis' Xolair for big new market in chronic hives
Fierce Pharma
Thu, 03/12/15 - 09:36 pm
Novartis
Xolair
chronic hives
UK
NICE
Bayer feels sting of mixed decision from NICE for Eylea's use in diabetics
Fierce Pharma
Fri, 02/20/15 - 05:41 pm
Bayer
NICE
Eylea
NICE backs thousands more scripts for clot-fighters Pradaxa, Xarelto, and Eliquis
Fierce Pharma
Thu, 06/19/14 - 10:36 am
NICE
Pradaxa
Xarelto
bloodthinners
Eliquis
Bayer
JNJ
Pfizer
Bristol-Myers Squibb
Boehringer Ingelheim
NICE rejects Roche's hot new breast cancer drug Kadcyla, then invites negotiations
Fierce Pharma
Wed, 04/23/14 - 12:02 pm
breast cancer
Roche
NICE
Kadcyla
HER2-positive metastatic breast cancer
Final NICE guidance rejects Sanofi's Zaltrap in colorectal cancer
First Word Pharma
Tue, 03/25/14 - 08:06 am
NICE
Sanofi
colorectal cancer
Zaltrap
Alexion’s $569,000 Drug Draws Data Demand From U.K. NICE
Bloomberg
Mon, 03/3/14 - 09:10 pm
Alexion
NICE
Soliris
Here's Why You Should Look Beyond NICE's Pushback on Tecfidera
Motley Fool
Mon, 02/24/14 - 05:01 pm
Tecfidera
NICE
MS
multiple sclerosis
Biogen Idec
Sanofi’s Aubagio Wins Final Approval From U.K. Cost Agency NICE
Bloomberg
Wed, 01/22/14 - 08:34 am
Sanofi
Aubagio
NICE
MS
multiple sclerosis
Novartis discount fails to persuade NICE on Afinitor in breast cancer
Fierce Pharma
Thu, 08/29/13 - 11:08 am
Novartis
NICE
breast cancer
Afinitor
1 Pharma Receiving Nice News (NVS)
Motley Fool
Wed, 10/10/12 - 11:16 am
NICE
Novartis
Lucentis
DME
diabetic macular edema

Pages